In the ongoing efforts to control and treat Alzheimer’s, one of the more promising avenues of research is using electromagnetic waves to reverse memory loss – and a small study using this approach has reported some encouraging results.
Category: biotech/medical – Page 2,390
Scientists get closer to a cure for the common cold
Despite the common cold being so — well — common, researchers have never succeeded in the long dream of curing or immunizing against the array of rhinoviruses that generally cause it. Though the common cold generally does not kill those who are not infirm or immunocompromised, it costs billions in lost time and energy. Now, new research hints that science might be closing in on the cold.
In a study to be published in Nature Microbiology, researchers at Stanford University and University of California, San Francisco say that the cure to the common cold could be the result of disabling one single host protein.
Advertisement:
Greg Fahy at Ending Age-Related Diseases 2019
We’re continuing to release talks from Ending Age-Related Diseases 2019, our highly successful two-day conference that featured talks from leading researchers and investors, bringing them together to discuss the future of aging and rejuvenation biotechnology.
Dr. Greg Fahy of Intervene Immune gave a presentation about his company’s Phase 1 human trials in which the thymus, a critical organ of the immune system, was regenerated through a combination of existing drugs, restoring immune function and causing epigenetic biomarkers to show rejuvenation.
Researchers alter mouse gut microbiomes
Humans choose food based on the way it looks, smells, and tastes. But the microbes in our guts use a different classification system — one that is based on the molecular components that make up different fibers. In a study published September 19 in the journal Cell, investigators found particular components of dietary fiber that encourage growth and metabolic action of beneficial microbes in the mouse gut.
The research aims to develop ways to identify compounds that can enhance the representation of health-promoting members of the gut microbial community. The goal is to identify sustainable, affordable dietary fiber sources for incorporation into next-generation, more nutritious food products.
“Fiber is understood to be beneficial. But fiber is actually a very complicated mixture of many different components,” says senior author Jeffrey Gordon, a microbiologist at the Washington University School of Medicine in St. Louis. “Moreover, fibers from different plant sources that are processed in different ways during food manufacturing have different constituents. Unfortunately, we lack detailed knowledge of these differences and their biological significance. We do know that modern Western diets have low levels of fiber; this lack of fiber has been linked to loss of important members of the gut community and deleterious health effects.”
New study links this common skin condition with an increased risk in heart disease
Over 3 million new cases of dermatitis appear in the US per year. Although dermatitis is broadly defined by the sensitivity of the skin, the condition is actually further segmented by a group of diseases. By far the most popular of these is atopic dermatitis, alternatively and perhaps more popularly known as eczema, affecting about 30% of the population. Genetics and environmental factors are the most conclusive predictors but no cause has ever been explicitly determined. The pathology is able to be determined physically, as inflamed skin grows craked and hardens.
Though a new report published in the Journal of the American Academy of Dermatology presents some internal risk increases for sufferers to consider. The Danish researchers set out to examine the association between hospital-diagnosed atopic dermatitis and atrial fibrillation, writing in the report, “Atopic dermatitis is characterized by chronic inflammation, which is a risk factor for atrial fibrillation. P atients with hospital-diagnosed atopic dermatitis have a 20% increased long-term risk of atrial fibrillation, but the absolute risk remains low.”
AgeX Therapeutics Publishes Theoretical Basis of Human Cell Age-Reversal in the Journal Regenerative Medicine
A unified theory of ageing, there is a vid and a paper linked within.
ALAMEDA, Calif.—( BUSINESS WIRE )—AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company focused on therapeutics for human aging and regeneration, announced today that founder and CEO Michael D. West, Ph.D., and colleagues have authored a paper in the peer-reviewed scientific journal Regenerative Medicine on the theoretical foundation of the Company’s induced Tissue Regeneration (iTRTM) technology. The paper presents the work of the company’s scientists in describing a unified theory of aging and regeneration that could pave the way for the development of new therapies for a variety of age-related degenerative diseases and conditions.
“The longevity sector is advancing at an accelerating pace, but for the most part, without a consensus on the fundamental root causes of aging,” commented Dr. West. “We believe that it is now possible to collate the diverse observations about aging into a unified model. In the paper titled, ‘Toward a Unified Theory of Aging and Regeneration’ we outline such a theory that underlies the technological underpinnings of the company’s induced tissue regeneration (iTR) program.”